Prevalence of bradyarrhythmias needing pacing in COVID-19.

Zaki AkhtarLisa Wm LeungChristos KontogiannisZia ZuberiAbhay BajpaiSumeet SharmaZhong ChenIan BeetonManav SohalMark M Gallagher

Published in: Pacing and clinical electrophysiology : PACE (2021)

High-degree AV block remained unaltered in prevalence during the COVID-19 pandemic. There was no evidence of transient high-degree AV block in patients with the Sars-Cov-2 infection. Our experience suggests that all clinically significant bradyarrhythmia should be treated by pacing according to usual protocols regardless of the COVID status.

Keyphrases

coronavirus disease
sars cov
risk factors
respiratory syndrome coronavirus
cardiac resynchronization therapy
heart failure
newly diagnosed